CD8 Antigen, alpha Chain (CD8A) antibody (FITC)

Details for Product No. ABIN135119
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms Ly-2, Ly-B, Ly-35, Lyt-2, BB154331, zgc:136643, cd8, LOC100136450
Reactivity
Mouse (Murine)
(33)
Host
Rat
(33)
Clonality (Clone)
Monoclonal ()
Conjugate
FITC
(5), (4), (3), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1)
Application
Flow Cytometry (FACS), Immunohistochemistry (IHC)
(32), (14), (3), (2)
Pubmed 7 references available
Catalog no. ABIN135119
Quantity 0.5 mg
Price
225.50 $   Plus shipping costs $45.00
Options
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Clone 53-6-7
Isotype IgG2a
Characteristics The antibody detects: chain of the murine CD8 heterodimer, Mr 32-34 kDa
The 53-6.7 monoclonal antibody also blocks allogeneic help specific for class I MHC antigens and T cell responses to IL-2.
Alternative Name CD8a/Ly-2
Background In the mouse, CD8 exists in two forms: (i) a CD8 heterodimer composed of an chain (CD8/Lyt-2) and a chain (CD8/Lyt-3), and (ii) a homodimer of two chains. The heterodimer is found on the surface of essentially all thymocytes and the suppressor/cytotoxic subpopulation of mature T lymphocytes. Subsets of intestinal intraepithelial lymphocytes express CD8 without CD8. It has been suggested that CD8+- T cells mature extrathymically, while development of the CD8++ population of T cells is thymus-dependent. CD8 acts as a coreceptor with MHC Class I-restricted T cell receptors in antigen recognition and positive selection of MHC class I-restricted CD8+ T cells. In vivo and in vitro treatment with the 53-6.7 monoclonal antibody effectively depletes CD8+ cells.
Application Notes Working Dilution:
FACS: 2 µg/10^6 cells
Representative data are included in this product insert.

Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
Comment

In vivo and in vitro depletion of CD8a+ cells

Sample Volume 1 mL
Restrictions For Research Use only
Buffer Product is supplied as 0.5 mg or 0.1 mg in 1.0 mL of PBS / NaN3.
Preservative Sodium azide
Precaution of Use WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Handling Advice Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed.
Storage 4 °C
Supplier Images
anti-CD8 Antigen, alpha Chain (CD8A) antibody (FITC) anti-CD8 Antigen, alpha Chain (CD8A) antibody (FITC)
Product cited in: Hintermann, Ehser, Christen: "The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice." in: Journal of visualized experiments : JoVE, Issue 60, 2012 (PubMed).

General Lefrancois: "Phenotypic complexity of intraepithelial lymphocytes of the small intestine." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 147, Issue 6, pp. 1746-51, 1991 (PubMed).

Lefrançois: "Extrathymic differentiation of intraepithelial lymphocytes: generation of a separate and unequal T-cell repertoire?" in: Immunology today, Vol. 12, Issue 12, pp. 436-8, 1992 (PubMed).

Takahasi, Kondou, Watanabe et al.: "[Investigation of etching and bonding on the inner surface of free enamel. SEM observation and thermal cycling test for pigment invasion]" in: Shika gakuho. Dental science reports, Vol. 89, Issue 3, pp. 663-8, 1990 (PubMed).

Ledbetter, Rouse, Micklem et al.: "T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views." in: The Journal of experimental medicine, Vol. 152, Issue 2, pp. 280-95, 1980 (PubMed).

Ledbetter, Seaman: "The Lyt-2, Lyt-3 macromolecules: structural and functional studies." in: Immunological reviews, Vol. 68, pp. 197-218, 1983 (PubMed).

Safari, Dekker, Rijkers et al.: "Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates." in: Vaccine, 2010 (PubMed).

Hosts (33)
Reactivities (33)
Applications (32), (14), (3), (2)
Conjugates (5), (4), (3), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1)
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Validation Images
back to top